5-Hydroxytryptophan artificial synaptic vesicles across the blood-brain barrier for the rapid-acting treatment of depressive disorder
Conventional antidepressants are slow to work and have serious side effects and poor response rates. As a precursor to 5-hydroxytryptamine (5-HT), 5-hydroxytryptophan (5-HTP) can be safely increased in concentration and rapidly metabolized into 5-HT in the brain, but the effectiveness of 5-HTP is se...
Saved in:
| Main Authors: | Peng Chang, Jingwen Ma, Ke Li, Wei Wang, Dan Chen, Zhe Liu, Wenhua Zhan, Yun Zeng, Yonghua Zhan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Materials Today Bio |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590006424004186 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Features of Risks in the Information Technology Industry
by: D. A. Predko
Published: (2021-04-01) -
High-throughput phenotyping using hyperspectral indicators supports the genetic dissection of yield in durum wheat grown under heat and drought stress
by: Rosa Mérida-García, et al.
Published: (2024-11-01) -
The Role of ROS in Electronic Cigarette- and Heated Tobacco Product-Induced Damage
by: Nancy E. Gomez, et al.
Published: (2024-09-01) -
Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson’s disease-like neurodegeneration
by: Hélèna L. Denis, et al.
Published: (2025-04-01) -
Improving treatment for Parkinson's disease: Harnessing photothermal and phagocytosis-driven delivery of levodopa nanocarriers across the blood-brain barrier
by: Kaili Liang, et al.
Published: (2024-12-01)